Skip to main content
Log in

Attention Deficit Disorder in Adults

  • Published:
Annals of Clinical Psychiatry

Abstract

ADHD/ADD, once thought to occur only in children, is now recognized as continuing into adulthood in many people. In order to be labeled as such, signs and symptoms must start before age 7 and are primarily characterized by inattention, distractibility, and impulsiveness. Although the exact mechanism is unknown, a number of associated neurochemical and structural abnormalities have been observed. This disorder can negatively affect the educational, social, and occupational lives of those who suffer from its symptoms. It interferes with the ability to establish and maintain close relationships. Pharmacotherapy remains the primary mode of treatment. Stimulants such as dextroamphetamine and methylphenidate are the main drugs utilized; they are available in immediate and longer duration versions. Bupropion is another important medicinal option, and there are a variety of other miscellaneous medications to consider, including modafinil, venlafaxine, tricyclic antidepressants, and guanfacine. Psychotherapy is shown to help control impulsiveness, form more satisfactory relationships, rear children more effectively, and improve organizational and problem-solving skills.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Weiss G, Hechtman L, Milroy T, Perlman T: Psychiatric status of hyperactives as adults:A controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 1985; 24:211–220

    Google Scholar 

  2. Gittelman R, Mannuzza S, Shenker R, Bonagura N: Hyperactive boys almost grown up, I: Psychiatric status. Arch Gen Psychiatry 1985; 42:937–947

    Google Scholar 

  3. Mannuzza S, Klein RG, Bonagura N, Malloy TL, Addali KA: Hyperactive boys almost grown up, V: Replication of psychiatric status. Arch Gen Psychiatry 1991; 48:77–83

    Google Scholar 

  4. Shaffer D: Attention deficit hyperactivity disorder in adults. Am J Psychiatry 1994; 151:633–638

    Google Scholar 

  5. Hill JC, Schoener EP: Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry 1996; 153(9):1143–1146

    Google Scholar 

  6. Wender PH: Attention deficit disorder in adults. Psychiatr Clin N Am 1998; 21(4):761–774

    Google Scholar 

  7. Faraone SV, Biederman J, Feighner JA, Monteaux MC: Assessing symptoms of attention deficit hyperactivity disorder in children and adults: Which is more valid. J Consult Clin Psychol 2001; 68(5):830–842

    Google Scholar 

  8. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C: Executive function and attention deficit hyperactivity disorder: Stimulant medication and better executive function performance in children. Psychol Med 1999; 29(3):527–538

    Google Scholar 

  9. Davis KL, Kahn RS, Ko G, Davidson M: Dopamine in schizophrenia: A review and reconceptualization. Am J Psychiatry 1991; 148(11):1474–1486

    Google Scholar 

  10. Castellanos FX, Ggiedd JN, EcKburg P, Marsh WL, Vaituzis AC, Kaysen D, Hamburger SD, Rapoport JL: Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 1994; 151:1791–1796

    Google Scholar 

  11. Castellanos FX, Giedo JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, Vauss YC, Snell JW, Rajapakse JC, Rapoport JL: Quantitative brain magnetic resonance imaging in attention deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53:607–616

    Google Scholar 

  12. Zametkin AJ, Liotta W: The neurobiology of attentiondeficit/ hyperactivity disorder. J Clin Psychiatry 1998; 59(7):17–23

    Google Scholar 

  13. Monastra VJ, Lubar JF, Linden M, Van Deusen P, Green G, Wing W, Phillips A, Fenger TN: Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: An initial validation study. Neuropsychology 1999; 13(3):424–433

    Google Scholar 

  14. West M: Attention Deficit/Hyperactive DisordersThrough the Lifespan, 2nd edn. South Easton, MA: Western Schools Press; 1999:50

    Google Scholar 

  15. Attention Deficit Disorder, Part II. Harvard Mental Health Letter, Vol. 9.Boston: Harvard Health Publications; 2000:1–3

  16. Attention Deficit Disorder, Part I. Harvard Mental Health Letter, Vol. 8. Boston: Harvard Health Publications; 2000:1–4

  17. Muglia P, Jain U, Macciardi F, Kennedy JL: Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet 2000; 96:273–277

    Google Scholar 

  18. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL: Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56:993–998

    Google Scholar 

  19. Barkley RA: Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 1997; 121(1):65–94

    Google Scholar 

  20. Biederman J: Attention-deficit/hyperactivity disorder: A lifespan perspective. J Clin Psychiatry 1998; 59(7):4–16

    Google Scholar 

  21. Spencer T, Biederman J, Wilens TE, Faraone SV: Adults with attention-deficit/hyperactivity disorder: A controversial diagnosis. J Clin Psychiatry 1998; 59(7):59–68

    Google Scholar 

  22. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association; 1994:78–85

  23. Murphy P, Schachar R: Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiatry 2000; 157(7):1156–1159

    Google Scholar 

  24. Ward MF, Wender PH, Reimherr FW: The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit disorder. Am J Psychiatry 1993; 150:885–890

    Google Scholar 

  25. Wender PH, Ward MF, Reimherr FW, Marchant BK: ADHD in adults. J Am Acad Child Adolesc Psychiatry 2000; 39(5):543–544

    Google Scholar 

  26. McCann BS, Scheele L, Ward N, Roy-Byrne P: Discriminant validity of the Wender Utah Rating Scale for attentiondeficit/ hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 2000; 12(2):240–245

    Google Scholar 

  27. Biederman J, Farone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehrman BK, Doyle A: Patterns of psychiatric comorbidity, cognition and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993; 1150:1792–1798

    Google Scholar 

  28. Schubiner H, Tzelepis A, Milberger S, Lockhart N, Kruger M, Kelley BJ, Schoener EP: Prevalence of attention deficit/ hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000; 61(4):244–251

    Google Scholar 

  29. Evans DL: Bipolar disorder: Diagnostic challenges and treatment considerations. J Clin Psychiatry 2000; 61(13):26–31

    Google Scholar 

  30. Bradley C: Behavior of children receiving benzedrine. Am J Psychiatry 1937; 94:577–585

    Google Scholar 

  31. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S: Pharmacology of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996; 35:409–432

    Google Scholar 

  32. Cooper JR, Bloom FE, Roth RH, eds.: Norepinephrine and epinephrine. In: Biochemical Basis of Neuropharmacology, 7th edn. New York: Oxford University Press; 1996:226–292

  33. Spencer T, Wilens TE, Biederman J, et al.: A double-blind crossover comparison of methylphenidate and placebo in adults with childhood-onset attention deficit hyperactivity. Arch Gen Psychiatry 1995; 52:434–444

    Google Scholar 

  34. Taylor FB, Russo J: Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol 2000; 10(4):311–320

    Google Scholar 

  35. Pelham WE, Gnagy EM, Chronic AM, Burrows-MacLean L, Fabiano GA, Onyango AN, Meichenbaum DL, Williams A, Aronoff HR, Steiner RL: A comparison of morningonly and morning/late afternoon adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit hyperactivity disorder. Pediatrics 1999; 104(6):1300–1311

    Google Scholar 

  36. Psychotropic Prescribing Guide, 4th edn.: Physicians Desk Reference. Montvale, NJ: Medical Economics Co.; 2001:140–148, 331–339, 344–355

  37. Horrigan JP, Barnhill LJ: Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J Clin Psychiatry 61(6):414–417

  38. Pelham WE, Gnagy EM, Burrows-Mclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD: Once-a-day concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 2001; 107(6):e105

    Google Scholar 

  39. Medical Letter, Inc. 2000; 42(1086):79–82

  40. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, PolisnerD, Slolhkhah R, Comeau S, Monuteaux MC, Parekh A: A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001; 158(2):282–288

    Google Scholar 

  41. Olvera RL, Pliszka SR, Luh J, Tatum R: An open trial of venlafaxine in the treatment of attention deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol 1996; 6:241–250

    Google Scholar 

  42. Upadhyaya MS, Brady KT, Sethuraman G, Sonne SC, Malcolm R: Venlafaxine treatment of patients with comorbid alcohol/ cocaine abuse and attention-deficit/hyperactivity disorder: A pilot study. J Clin Psychopharmacol 2001; 21(1):116–118

    Google Scholar 

  43. Sallee FR, Stiller RL, Perel JM, Everett G: Pemoline-induced abnormal involuntary movements. J Clin Psychopharmacol 1998; 9:125–129

    Google Scholar 

  44. Biederman J, Thisted RA, Greenhill LL, Ryan ND: Estimation of the association between desipramine and the risk for sudden death in 5 to 14-year-old children. J Clin Psychiatry 1995; 56:87–93

    Google Scholar 

  45. Varley CK, McClellan J: Case study: Two additional sudden deaths with tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry 1997; 36:390–394

    Google Scholar 

  46. Elia J, Ambrosini PJ, Rapoport JL: Treatment of attentiondeficit-hyperactivity disorder. N Engl J Med 1999; 340(10): 780–788

    Google Scholar 

  47. Taylor FB, Russo J: Comparing guanfacine and dextroamphetamine for the treatment of adult attention deficit/hyperactivity disorder. Clin Psychopharmacol 2001; 21(2):223–228

    Google Scholar 

  48. Murphy K: Adults with attention hyperactivity disorder: Assessment and treatment considerations. Semin Speech Lang 1996; 17(3):245–254

    Google Scholar 

  49. Lubar JF, Lubar JO: Neurofeedback: Assessment and treatment for attention deficit/hyperactivity disorders: Introduction to quantitative EEG and neurofeedback. In: Evans JR, Arbaranel A, eds. Introduction to QuantitativeEEGand Neurofeedback. San Diego: Academic Press; 1999:103–142

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pary, R., Lewis, S., Matuschka, P.R. et al. Attention Deficit Disorder in Adults. Ann Clin Psychiatry 14, 105–111 (2002). https://doi.org/10.1023/A:1016807021779

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016807021779

Navigation